Federal Minister of Health tables the 2022 Annual Report of the Patented Medicine Prices Review Board
Government of Canada
“The Honourable Mark Holland, Federal Minister of Health, today tabled the 2022 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the Senate and the House of Commons.”
KEYWORDS: Patented Medicine Prices Review Board (PMPRB), Government of Canada
uOttawa scientists develop novel radiotracer for earlier detection of disease
University of Ottawa
“For the first time, we can see where fructose, a common dietary sugar, is used in the body. Outside of the kidneys and the liver, fructose metabolism in any other organs may point to a sinister problem …”
KEYWORDS: cancer, Canadian research, University of Ottawa, University of Ottawa Heart Institute
Researchers are using RNA in a new approach to fight HIV
University of Waterloo
“This is the first research to develop a combination nanomedicine that can reactivate autophagy and prevent HIV entry into cells, allowing our body to re-initiate its defence system.”
KEYWORDS: HIV, innovative research, University of Waterloo
Preventing Cervical Cancer Starts Here
Roche Canada
“With self-sampling, an individual with a cervix can now privately collect their vaginal sample following instructions provided by a healthcare worker. This option helps reduce various burdens for cervical screening.”
KEYWORDS: cancer, women’s health, Roche Canada
| FUNDING OPPORTUNITY Canadian Nuclear Research Initiative: Health (CNRI-H) | Deadline March 11, 2024 Canadian Nuclear Laboratories (CNL) “The CNRI-H program was developed by CNL to further the realization of its mission by making its expertise, experience and capabilities available and accessible to the healthcare community to advance new life saving radiopharmaceutical therapies. On Thursday, February 22, 2024, CNL will be hosting a live webinar to provide an overview of CNRI-H for organizations interested in applying. To register for the webinar, visit www.cnl.ca/RSVP.” |